date founded

General

About Company
Quercus Molecular Design is developing small molecule inhibitors to treat infectious diseases and cancer.

Industry

Sector :

Subsector :

Keywords :

Also Known As

QMD

founded date

01.01.2015

Number of employees

Company Type

For Profit

IPO status

Private
Similar Companies
1000
Virobay

Virobay

Virobay develops antiviral drugs for autoimmune diseases, neuropathic pain, liver diseases, and cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Menlo Park, CA, USA

total rounds

4

total raised

$23.77M
MedWell Laboratories

MedWell Laboratories

Developing enzyme inhibiting small molecule drugs for inflammatory disorders

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Biopharma, Health Care

Location

9810 Nazareth, Belgium
PRISM BioLab

PRISM BioLab

PRISM BioLab develops small molecule technologies to treat incurable diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Fujisawa, Kanagawa, Japan

total rounds

6

total raised

$42.14M
Syntrix Pharmaceuticals

Syntrix Pharmaceuticals

Syntrix is a biotech company developing small molecule therapeutics for pain and pulmonary diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Auburn, WA, USA

Financials

Co-Investors

People

Employee Profiles
1
Sandra K. Weller

Sandra K. Weller

Founder and Chief Biology Officer

Activity

Recent News
0